Compound Detail
CHEMBL1951065
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1951065 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NOURAPILDFIPLX-UHFFFAOYSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
510.6
MW (Da)
2.65
ALogP
8
HBA
4
HBD
132.7
PSA (Ų)
0.21
QED
1
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 7.7
IC50 1 meas. best 6.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL5414 | EC50 | 7.7 | 7.7 | 19.9 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4B CHEMBL275 | IC50 | 6.55 | 6.55 | 280.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Beta-2 adrenergic receptor | EC50 | = | 19.95 | nM | 7.7 | Agonist activity at beta2 adrenoceptor in guinea pig assessed as relaxation of h... | 22297114 |
| 3',5'-cyclic-AMP phosphodiesterase 4B | IC50 | = | 280.0 | nM | 6.55 | Inhibition of human recombinant PDE4B2-mediated cAMP hydrolysis for 30 mins by c... | 22297114 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22297114 | 10.1016/j.bmcl.2012.01.013 | Beta-2 adrenergic receptor | 3 |
| 22297114 | 10.1016/j.bmcl.2012.01.013 | 3',5'-cyclic-AMP phosphodiesterase 4B | 1 |
Data from ChEMBL 36 via Core Engine